# OvaScience

OvaScience is an other based in Waltham, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Waltham, United States
- **Region:** North America
- **Address:** Waltham, MA, United States
- **Assets under management:** Undisclosed
- **Website:** ovascience.com
- **LinkedIn:** https://www.linkedin.com/company/ovascience

## Regulatory record

- **Reports private funds:** No

## About

OvaScience is a biotechnology company founded in 2011 in Waltham, Massachusetts. It focuses on developing treatments for infertility, including OvaPrime, OvaTure, and AUGMENT, which is available in Japan through a partnership with IVF Japan. OvaTure and AUGMENT are designed to provide fertility treatment without hormone stimulation.

## Sectors

- Healthcare Services

## Questions

### What happened to OvaScience after its Nasdaq delisting?

OvaScience delisted from Nasdaq in 2017 following product development setbacks and a strategic review. It reorganized as a private entity, but the exact ownership structure and capital sources have not been publicly disclosed.

### What is the science behind OvaScience's fertility treatments?

OvaScience's platform is based on egg precursor cells, also known as oogonial stem cells, which are intended to be harvested and reactivated to improve ovarian function. This approach was developed from animal research and is patented, though it has not achieved commercial success.

## Related profiles

- [NSW Ministry of Health](https://altss.com/profile/nsw-ministry-of-health)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ovascience

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology